No bill whose main goal is changing the legal status of psychedelics will get a formal vote on the floor of the US House or Senate in 2026. Congress has a packed schedule of budget fights and election-year politics, and historically any psychedelic policy wins have been slipped into bigger bills — not pushed as standalone laws.
The 2026 floor calendar is dominated by appropriations fights and election-year messaging bills, leaving no realistic window for controversial standalone drug-policy legislation. Historical precedent supports this: psychedelic policy has moved exclusively through NDAA amendments and appropriations riders since 2023. Resolution criteria: resolves NO if any bill whose primary purpose is psychedelic rescheduling or legalization passes a recorded floor vote in the House or Senate by 2026-12-31; riders and amendments to must-pass vehicles do not count against this prediction.